- Home
- RCUS vs EMO Comparison
RCUS vs EMO Comparison
Compare RCUS & EMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- EMO
- Stock Information
- Founded
- RCUS 2015
- EMO 2011
- Country
- RCUS United States
- EMO United States
- Employees
- RCUS N/A
- EMO N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- EMO Investment Managers
- Sector
- RCUS Health Care
- EMO Finance
- Exchange
- RCUS Nasdaq
- EMO Nasdaq
- Market Cap
- RCUS 727.1M
- EMO 599.1M
- IPO Year
- RCUS 2018
- EMO N/A
- Fundamental
- Price
- RCUS $7.88
- EMO $44.93
- Analyst Decision
- RCUS Strong Buy
- EMO
- Analyst Count
- RCUS 10
- EMO 0
- Target Price
- RCUS $29.50
- EMO N/A
- AVG Volume (30 Days)
- RCUS 1.2M
- EMO 27.1K
- Earning Date
- RCUS 05-07-2025
- EMO 01-01-0001
- Dividend Yield
- RCUS N/A
- EMO 6.70%
- EPS Growth
- RCUS N/A
- EMO N/A
- EPS
- RCUS N/A
- EMO N/A
- Revenue
- RCUS $258,000,000.00
- EMO N/A
- Revenue This Year
- RCUS N/A
- EMO N/A
- Revenue Next Year
- RCUS $25.77
- EMO N/A
- P/E Ratio
- RCUS N/A
- EMO N/A
- Revenue Growth
- RCUS 120.51
- EMO N/A
- 52 Week Low
- RCUS $6.50
- EMO $26.42
- 52 Week High
- RCUS $18.98
- EMO $40.17
- Technical
- Relative Strength Index (RSI)
- RCUS 44.26
- EMO 45.02
- Support Level
- RCUS $6.75
- EMO $40.04
- Resistance Level
- RCUS $8.36
- EMO $43.95
- Average True Range (ATR)
- RCUS 0.60
- EMO 2.18
- MACD
- RCUS 0.16
- EMO -0.14
- Stochastic Oscillator
- RCUS 74.19
- EMO 48.13
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About EMO ClearBridge Energy Midstream Opportunity Fund Inc.
ClearBridge Energy Midstream Opportunity Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide long-term investors with a high level of total return with an emphasis on cash distributions.